By Frank Prenesti
Date: Monday 11 Sep 2023
LONDON (ShareCast) - (Sharecast News) - Syncona shares fell as the UK healthcare investment firm said Novartis had stopped the development of experimental eye treatment, GT005, resulting in milestone payments write-off of £54.5m for Gyroscope Holdings in which Syncona once held a 54% stake.
Gyroscope was sold to Novartis in February last year in $1.5bn deal, with Syncona receiving $442m (£326m) for its stake.
Email this article to a friend
or share it with one of these popular networks:
| Currency | UK Pounds |
| Share Price | 93.30p |
| Change Today | -0.70p |
| % Change | -0.74 % |
| 52 Week High | 105.60p |
| 52 Week Low | 79.70p |
| Volume | 155,210 |
| Shares Issued | 608.19m |
| Market Cap | £567.44m |
| RiskGrade | 291 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 21-Jun-18 | 20-Jul-17 |
| Paid | 30-Jul-18 | 23-Aug-17 |
| Amount | 2.30p | 2.30p |
| Time | Volume / Share Price |
| 13:32 | 3,260 @ 93.49p |
| 13:31 | 3,000 @ 93.94p |
| 12:35 | 1,322 @ 93.30p |
| 12:35 | 8,368 @ 93.30p |
| 12:35 | 1 @ 93.30p |
You are here: research